CJC-1295 no DAC + Ipa

This dual-sequence composite is engineered for high-fidelity laboratory applications requiring the simultaneous evaluation of two distinct signaling pathways. By utilizing a 1:1 molecular ratio of a selective GHRH-agonist and a specific Ghrelin-receptor ligand, this formulation ensures high-resolution data in cellular signaling studies.